Adiponectin levels are inversely related to insulin resistance and are lower in obese subjects and patients with established insulin resistance, e.g., in type 2 diabetes, NAFLD/NASH and hypertension. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.